131 related articles for article (PubMed ID: 22994731)
1. Presence of anemia and poor prognostic factors in patients with endometrial carcinoma.
Wilairat W; Benjapibal M
Asian Pac J Cancer Prev; 2012; 13(7):3187-90. PubMed ID: 22994731
[TBL] [Abstract][Full Text] [Related]
2. Preoperative thrombocytosis and poor prognostic factors in endometrial cancer.
Heng S; Benjapibal M
Asian Pac J Cancer Prev; 2014; 15(23):10231-6. PubMed ID: 25556452
[TBL] [Abstract][Full Text] [Related]
3. Preoperative hemoglobin and platelet count and poor prognostic factors in patients with endometrial carcinoma.
Metindir J; Bilir Dilek G
J Cancer Res Clin Oncol; 2009 Jan; 135(1):125-9. PubMed ID: 18542999
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma.
Tamussino KF; Gücer F; Reich O; Moser F; Petru E; Scholz HS
Int J Gynecol Cancer; 2001; 11(3):236-40. PubMed ID: 11437932
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group study.
Tal O; Eitan R; Gemer O; Helpman L; Vaknin Z; Leytes S; Lavie O; Ben-Arie A; Amit A; Namazov A; Ben Shahar I; Atlas I; Bruchim I; Levy T
Int J Gynecol Cancer; 2021 Nov; 31(11):1437-1442. PubMed ID: 34725243
[TBL] [Abstract][Full Text] [Related]
6. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer.
Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S
Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Anemia as a Prognostic Factor in Endometrioid-Type Endometrial Carcinoma.
Abu-Zaid A; Alsabban M; Abuzaid M; Alomar O; Salem H; Al-Badawi IA
J Obstet Gynaecol Can; 2018 Nov; 40(11):1393-1400. PubMed ID: 30473117
[TBL] [Abstract][Full Text] [Related]
8. [Clinical implications of positive peritoneal cytology in endometrial cancer].
Ren YL; Wang HY; Shan BE; Ping B; Shi DR
Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma.
Bildrici K; Tel N; Ozalp SS; Yalcin OT; Yilmaz V
Eur J Gynaecol Oncol; 2002; 23(6):540-4. PubMed ID: 12556100
[TBL] [Abstract][Full Text] [Related]
11. Preoperative anemia predicts poor prognosis in patients with endometrial cancer: A systematic review and meta-analysis.
Abu-Zaid A; Alomar O; Abuzaid M; Baradwan S; Salem H; Al-Badawi IA
Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():382-390. PubMed ID: 33529973
[TBL] [Abstract][Full Text] [Related]
12. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
13. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer.
Chung HH; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Acta Obstet Gynecol Scand; 2006; 85(12):1501-5. PubMed ID: 17260229
[TBL] [Abstract][Full Text] [Related]
14. [Multivariate analysis of prognostic factors in endometrial carcinoma].
Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
[TBL] [Abstract][Full Text] [Related]
15. Parametrial spread is a prognostic factor in endometrial carcinoma.
Sato R; Jobo T; Kuramoto H
Eur J Gynaecol Oncol; 2003; 24(3-4):241-5. PubMed ID: 12807232
[TBL] [Abstract][Full Text] [Related]
16. Treatment results of endometrial carcinoma with positive peritoneal washing, adnexal involvement and serosal involvement.
Wong FC; Pang CP; Tang SK; Tung SY; Leung TW; Sze WK; Cheung KB
Clin Oncol (R Coll Radiol); 2004 Aug; 16(5):350-5. PubMed ID: 15341439
[TBL] [Abstract][Full Text] [Related]
17. Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer.
Chen YL; Huang CY; Chien TY; Huang SH; Wu CJ; Ho CM
Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):397-402. PubMed ID: 21806586
[TBL] [Abstract][Full Text] [Related]
18. The relationship between mutant p53 gene, DNA contents and conventional clinicopathological prognostic variables in cases with endometrial carcinoma.
Osmanağaoğlu MA; Kadioğlu S; Osmanağaoğlu S; Bozkaya H; Reis A; Tekelioğlu Y
Eur J Gynaecol Oncol; 2005; 26(1):64-70. PubMed ID: 15755004
[TBL] [Abstract][Full Text] [Related]
19. The Significance of Pretreatment Thrombocytosis and Its Association With Neutrophilia in Patients With Surgically Treated Endometrial Cancer.
Takahashi R; Mabuchi S; Kuroda H; Kozasa K; Yokoi E; Matsumoto Y; Kimura T
Int J Gynecol Cancer; 2017 Sep; 27(7):1399-1407. PubMed ID: 28604454
[TBL] [Abstract][Full Text] [Related]
20. Adnexal Involvement in Endometrial Cancer: Prognostic Factors and Implications for Ovarian Preservation.
Baiocchi G; Clemente AG; Mantoan H; da Costa WL; Bovolim G; Guimaraes APG; da Costa AABA; De Brot L; Faloppa CC
Ann Surg Oncol; 2020 Aug; 27(8):2822-2826. PubMed ID: 32080810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]